Ngā hua rapu - Qintao Ge
- E whakaatu ana i te 1 - 12 hua o te 12
-
1
Overexpression of DDX49 in prostate cancer is associated with poor prognosis mā Junyue Tao, Qintao Ge, Jialing Meng, Chaozhao Liang, Zongyao Hao, Jun Zhou
I whakaputaina 2023-04-01
Tuhinga -
2
Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy mā Zichen Bian, Jia Chen, Chang Liu, Qintao Ge, Meng Zhang, Jialin Meng, Chaozhao Liang
I whakaputaina 2023-01-01
Tuhinga -
3
-
4
Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction mā Qintao Ge, Zhijie Zhao, Xiao Li, Feixiang Yang, Meng Zhang, Zongyao Hao, Chaozhao Liang, Jialin Meng
I whakaputaina 2024-01-01
Tuhinga -
5
Macrophages and monocytes mediated activation of oxidative phosphorylation implicated the prognosis and clinical therapeutic strategy of Wilms tumour mā Jialin Meng, Yonghao Chen, Xiaofan Lu, Qintao Ge, Feixiang Yang, Suwen Bai, Chaozhao Liang, Juan Du
I whakaputaina 2022-01-01
Tuhinga -
6
-
7
EPM2A acts as a protective factor in prostate cancer, evidence from a real-world patient cohort mā Qintao Ge, Qintao Ge, Qintao Ge, Jiawei Li, Jiawei Li, Jiawei Li, Junyue Tao, Junyue Tao, Junyue Tao, Rui Gao, Rui Gao, Rui Gao, Chen Jin, Chen Jin, Chen Jin, Jun Zhou, Jun Zhou, Jun Zhou, Meng Zhang, Meng Zhang, Meng Zhang, Zongyao Hao, Zongyao Hao, Zongyao Hao, Jialin Meng, Jialin Meng, Jialin Meng, Chaozhao Liang, Chaozhao Liang, Chaozhao Liang
I whakaputaina 2022-09-01
Tuhinga -
8
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy mā Jialin Meng, Xiaofan Lu, Yujie Zhou, Meng Zhang, Qintao Ge, Jun Zhou, Zongyao Hao, Shenglin Gao, Fangrong Yan, Chaozhao Liang
I whakaputaina 2021-03-01
Tuhinga -
9
Insights from immunomics and metabolomics on the associations between prostatic diseases and coronavirus disease 2019 mā Feixiang Yang, Peng Guo, Kun Wang, Xiangyu Zhang, Zhehao Hu, Qiyue Lou, Qintao Ge, Yiding Chen, Chaozhao Liang, Jialin Meng
I whakaputaina 2024-09-01
Tuhinga -
10
Integrated analysis of histone modification features in clear cell renal cancer for risk stratification and therapeutic prediction mā Wenming Ma, Qintao Ge, Yu Guan, Li Zhang, Liqun Huang, Lei Chen, Wenlong Xu, Jialin Meng, Guosheng Yang, Chaozhao Liang
I whakaputaina 2024-09-01
Tuhinga -
11
Integrated multi‐omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer mā Jialin Meng, Xiaofan Lu, Chen Jin, Yujie Zhou, Qintao Ge, Jun Zhou, Zongyao Hao, Fangrong Yan, Meng Zhang, Chaozhao Liang
I whakaputaina 2021-12-01
Tuhinga -
12
Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy mā Jialin Meng, Aimin Jiang, Xiaofan Lu, Di Gu, Qintao Ge, Suwen Bai, Yundong Zhou, Jun Zhou, Zongyao Hao, Fangrong Yan, Linhui Wang, Haitao Wang, Juan Du, Chaozhao Liang
I whakaputaina 2023-11-01
Tuhinga